The combination of higher serum oxidized low-density lipoprotein (oxLDL) and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for transient ischemic attacks.
Discontinuation of vitamin K antagonist oral anticoagulant therapy was associated with an elevated risk for stroke or transient ischemic attack in patients newly diagnosed with nonvalvular atrial fibrillation.
In patients with ischemic stroke and TIA there is a significant gap between cerebrovascular risk factors control and real-world stroke prevention.
The UK FAST campaign attempted to bolster patient response to both transient ischemic attack and minor stroke.
The rate of a composite of stroke, acute coronary syndrome, or death from cardiovascular causes occurred in 12.9% of patients; 50.1% of events occurring in the second to fifth years.
The combination of clopidogrel and aspirin was associated with a reduced risk for major ischemic events, but also with increased risk for major hemorrhage within 90 days.
Investigators assessed the impact of infarction patterns on the safety and effectiveness of dual antiplatelet therapy with clopidogrel and aspirin.
Independent risk factors for urgency urinary incontinence included previous stroke or transient ischemic attack, increased body mass index, and hypertension.
Care quality for patients with transient ischemic attack or minor stroke varies substantially across elements of care and facilities.
Pioglitazone is associated with greater benefit for those at higher risk for stroke or myocardial infarction after an ischemic attack or transient ischemic attack.
